Cyclosporine: A Review

The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing....

Full description

Bibliographic Details
Main Authors: Dustin Tedesco, Lukas Haragsim
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2012/230386
id doaj-c2ab94c217e343c6b5b3fcb58856033a
record_format Article
spelling doaj-c2ab94c217e343c6b5b3fcb58856033a2020-11-24T22:58:03ZengHindawi LimitedJournal of Transplantation2090-00072090-00152012-01-01201210.1155/2012/230386230386Cyclosporine: A ReviewDustin Tedesco0Lukas Haragsim1Division of Nephrology and Hypertension, University of Oklahoma Health Sciences Center, 920 S. L. Young Blvd, WP 2250 Oklahoma City, OK 73104, USADivision of Nephrology and Hypertension, University of Oklahoma Health Sciences Center, 920 S. L. Young Blvd, WP 2250 Oklahoma City, OK 73104, USAThe discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing. The finding of acute reversible nephrotoxicity and nephrotoxicity in nonrenal transplants has since led to the widely accepted view that there is a chronic more irreversible component to this agent as well. Since that time, there has been intense interest in finding protocols which seek to minimize and even avoid the use of calcineurin inhibitors altogether. We seek to review cyclosporine in terms of its mechanism of action, pathophysiologic, and histologic features associated with acute and chronic nephrotoxicity and recent studies looking to avoid its toxic side effects.http://dx.doi.org/10.1155/2012/230386
collection DOAJ
language English
format Article
sources DOAJ
author Dustin Tedesco
Lukas Haragsim
spellingShingle Dustin Tedesco
Lukas Haragsim
Cyclosporine: A Review
Journal of Transplantation
author_facet Dustin Tedesco
Lukas Haragsim
author_sort Dustin Tedesco
title Cyclosporine: A Review
title_short Cyclosporine: A Review
title_full Cyclosporine: A Review
title_fullStr Cyclosporine: A Review
title_full_unstemmed Cyclosporine: A Review
title_sort cyclosporine: a review
publisher Hindawi Limited
series Journal of Transplantation
issn 2090-0007
2090-0015
publishDate 2012-01-01
description The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing. The finding of acute reversible nephrotoxicity and nephrotoxicity in nonrenal transplants has since led to the widely accepted view that there is a chronic more irreversible component to this agent as well. Since that time, there has been intense interest in finding protocols which seek to minimize and even avoid the use of calcineurin inhibitors altogether. We seek to review cyclosporine in terms of its mechanism of action, pathophysiologic, and histologic features associated with acute and chronic nephrotoxicity and recent studies looking to avoid its toxic side effects.
url http://dx.doi.org/10.1155/2012/230386
work_keys_str_mv AT dustintedesco cyclosporineareview
AT lukasharagsim cyclosporineareview
_version_ 1725648575768035328